OakChart

Icon Plc

ICLRHealthcare·Diagnostics & Research·Ireland·Large·NASD·Nov 11 • 3:12 PM ET

200.75-3.88 (-1.89%)
2026-11-11 21:13 CET
Market cap
15,330.20 USD m
Revenue, TTM
8,234.76 USD m
Net income, TTM
448.66 USD m
Free cash flow, TTM
829.71 USD m
EPS diluted, TTM
5.80
P/E
34.60
Compare

Price

ICLR against its 20, 50 and 200-day averages
2050200beatmiss
125.00150.00175.00200.00225.002.0M3.9MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ICLRclose 200.7520-day 194.1450-day 177.60200-day 146.58200.7552w high

8.3% under the 52-week high of 219.04 on 29 Oct 2026. 52-week low 66.57 on 12 Feb 2026. Last 15 sessions, 22.3% high to low

Volume 0.30× normal · the line is the 50-bar volume average

Profile

ICLR
52-week range, 88% of the way up
66.57219.04

ICON plc engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm specializes in the development, management, and analysis of programs that support clinical development. It operates through the following geographical segments: Ireland, Rest of Europe, U.S., and Rest of World. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.

Employees40100
IPOMay 15, 1998
Beta1.18
ATR, 14d8.69
Rel volume0.30
Short float3.20%
Insider own1.05%
Inst own108.41%

Snapshot

6 groups

Valuation

Index-
Market Cap15.04B
Enterprise Value17.74B
Income448.66M
Sales8.23B
Book/sh121.83
Cash/sh10.80
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees40100
IPOMay 15, 1998

Ratios

P/E34.60
Forward P/E17.28
PEG10.17
P/S1.83
P/B1.65
P/C18.59
P/FCF18.13
EV/EBITDA14.79
EV/Sales2.15
Quick Ratio1.32
Current Ratio1.32
Debt/Eq0.38
LT Debt/Eq0.38
Option/ShortYes / Yes

Earnings

EPS (ttm)5.80
EPS next Y11.62
EPS next Q2.83
EPS this Y-15.55%
EPS next Y9.77%
EPS next 5Y1.70%
EPS past 3/5Y-22.33% -14.31%
Sales past 3/5Y2.15% 24.15%
EPS Y/Y TTM43.70%
Sales Y/Y TTM0.67%
EPS Q/Q142.96%
Sales Q/Q-2.86%
EarningsOct 27 AMC
EPS/Sales Surpr.1.65% 0.61%

Ownership

Insider Own1.05%
Insider Trans-4.19%
Inst Own108.41%
Inst Trans-1.89%
ROA2.77%
ROE4.95%
ROIC3.56%
Gross Margin18.99%
Oper. Margin9.62%
Profit Margin5.45%
SMA203.41%
SMA5013.04%
SMA20036.95%
Trades-

Technical

Shs Outstand74.92M
Shs Float74.13M
Short Float3.20%
Short Ratio2.48
Short Interest2.37M
52W High219.04 -8.35%
52W Low66.57 201.57%
Volatility3.66% 4.63%
ATR (14)8.69
RSI (14)59.26
Beta1.18
Rel Volume0.30
Avg Volume955.65K
Volume253,372

Performance

Perf Week-1.16%
Perf Month22.16%
Perf Quarter19.87%
Perf Half Y71.03%
Perf YTD10.17%
Perf Year22.84%
Perf 3Y-21.68%
Perf 5Y-27.05%
Perf 10Y150.35%
Recom1.95
Target Price234.50
Prev Close204.63
Price200.75
Change %-1.89%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 09, 2026UpgradeBBofA SecuritiesUnderperform → Neutral$185-7.8%
Sep 30, 2026ResumedUUBSNeutral$195-2.9%
Jun 30, 2026UpgradeTTruistHold → Buy$207+3.1%
Jun 25, 2026UpgradeRRBC Capital MktsSector Perform → Outperform$185-7.8%
May 18, 2026ResumedRRBC Capital MktsSector Perform$123-38.7%
Mar 26, 2026UpgradeBBMO Capital MarketsMarket Perform → Outperform$130-35.2%
Feb 23, 2026UpgradeJJefferiesHold → Buy$135-32.8%
Feb 18, 2026UpgradeTTD CowenHold → Buy$120-40.2%
Feb 17, 2026DowngradeRRothschild & Co RedburnBuy → Neutral$100-50.2%
Feb 12, 2026DowngradeLLeerink PartnersOutperform → Market Perform$105-47.7%

Peers

Mkt cap
TickerCompanyMkt cap
MEDPMedpace Holdings Inc18.58B
IQVIQVIA Holdings Inc45.67B
FTREFortrea Holdings Inc2.02B
LHLabcorp Holdings Inc30.14B
TMOThermo Fisher Scientific Inc266.12B
CRLCharles River Laboratories International Inc16.66B
VEEVVeeva Systems Inc49.80B
CERTCertara Inc1.79B
TEMTempus AI Inc14.57B
AZTAAzenta Inc2.14B

Insider trading

latest 14 of 37
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Murray CiaranDirectorNov 02 '26Sale205.663,452709,95617,000Nov 04 06:30 AM
Balfe Barry EdwardChief Executive OfficerNov 02 '26Sale206.665,1751,069,4419,291Nov 03 04:23 PM
Lyons EmerChief Accounting OfficerNov 02 '26Sale206.6626454,5581,217Nov 03 04:16 PM
Clerkin Nigel Bernard JohnChief Financial OfficerNov 02 '26Sale206.661,488307,5037,171Nov 03 04:11 PM
NIGEL CLERKINOfficerNov 02 '26Proposed Sale206.651,488307,501Nov 02 04:11 PM
CIARAN MURRAYDirectorNov 02 '26Proposed Sale205.663,452709,956Nov 02 04:10 PM
BARRY EDWARD BALFEOfficerNov 02 '26Proposed Sale206.655,1751,069,434Nov 02 04:06 PM
Lyons EmerChief Accounting OfficerOct 23 '26Sale182.3727249,604990Oct 26 06:57 AM
CLIMAX JOHN DRDirectorSep 16 '26Option Exercise125.745,005629,3297,092Sep 18 06:08 AM
CLIMAX JOHN DRDirectorSep 16 '26Sale175.005,005875,8752,087Sep 18 06:08 AM
McCague Eugene PacelliDirectorSep 17 '26Option Exercise125.743,255409,2847,066Sep 18 06:08 AM
McCague Eugene PacelliDirectorSep 17 '26Sale175.003,255569,6253,811Sep 18 06:08 AM
Murphy Ronan MartinDirectorSep 17 '26Option Exercise125.745,005629,3298,852Sep 18 06:07 AM
Murphy Ronan MartinDirectorSep 17 '26Sale175.005,005875,8753,847Sep 18 06:07 AM

Held by

AUM
TickerCompanyAUM
SEQSequoia ETFAUM: 7.04B
DFSVUS Small Cap Value Portfolio ETF Class SharesAUM: 8.52B
DFATU.S. Targeted Value Portfolio-ETF Class SharesAUM: 14.47B
PIEQPrincipal International Equity ETFAUM: 1.36B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
LYRLyrical U.S. Value Equity ETFAUM: 1.22B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
SPDWState Street SPDR Portfolio Developed World ex-US ETFAUM: 41.64B
OAKLOakmark U.S. Concentrated ETFAUM: 336.46M
TSMEThrivent Small-Mid Cap Equity ETFAUM: 841.53M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-272.6602.6171.5802,0252,01317
2026Q22026-07-292.5602.5450.9382,0632,00416
2026Q12026-06-232.5002.4321.3562,0341,99816
2025Q42026-05-272.5203.1281.9302,1131,98215
2025Q32025-10-223.3103.301-3.6732,0431,98316
2025Q22025-07-233.2603.1882.5582,0171,98216
2025Q12025-04-303.1903.1051.9872,0012,00816
2024Q42025-02-193.4303.4293.1622,0412,03618
2024Q32024-10-233.3503.8512.3622,0302,13417
2024Q22024-07-243.7503.6821.7622,1202,13716
2024Q12024-04-243.4703.4112.2522,0902,08715
2023Q42024-02-213.4603.4592.6042,0662,09115
2023Q32023-10-253.3003.2731.9732,0552,05315
2023Q22023-07-263.1103.0761.3992,0202,01815
2023Q12023-04-262.9002.8751.4121,9791,97915
2022Q42023-02-223.1303.0651.4241,9621,96414

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY6.8806.8896.8832,8062,813
2020FY6.5306.4616.2372,7972,790
2021FY9.6509.6762.2515,4815,494
2022FY11.75011.6886.1277,7417,745
2023FY12.79012.7737.4038,1208,144
2024FY14.00013.9888.9028,2828,279
2025FY12.53012.8802.9008,2518,035
2026FY-10.581--8,164
2027FY-11.615--8,541
2028FY-13.180--9,091
2029FY-15.246--9,826
2030FY-16.453--10,387

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2914722,0402,0262,071
2026Q4S2026-10-2814712,0462,0262,103
2026Q4S2026-10-2714112,0271,9952,103
2026Q4S2026-10-2014112,0271,9952,103
2026Q4S2026-10-1914112,0271,9952,103
2026Q4S2026-10-1614112,0271,9952,103
2026Q4S2026-10-1314112,0271,9952,103
2026Q4S2026-10-0914522,0271,9952,103
2026Q4S2026-10-0214522,0271,9952,103
2026Q4S2026-09-2814512,0301,9952,103
2026Q4S2026-09-1713512,0301,9952,103
2026Q4S2026-09-1613422,0251,9602,103
2026Q4S2026-09-0513432,0251,9602,103
2026Q4S2026-08-1214432,0221,9602,103

Estimate history

EPS, annual5.135.8896.8836.2372.2516.1277.4038.9022.9045.8016
Period201720182019202020212022202320242025TTM
EPS, quarterly2.3623.1621.9872.558-3.6731.931.3560.9381.578
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1758.4392595.7772805.8392797.2885480.8267741.3868120.1768188.998251.348234.76
Period201720182019202020212022202320242025TTM
Sales, quarterly2030.032041.1012015.322039.0882084.4152112.5172033.9992063.4862024.757
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual54.08253.97253.62252.78881.55581.72482.49580.75776.56774.917
Period201720182019202020212022202320242025MRQ
Shares, quarterly82.55980.75782.68482.81777.77276.56776.60277.15474.917
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue8,234.768,251.348,188.998,120.187,741.395,480.832,797.292,805.842,595.78
Cost of Goods Sold Incl. D&A6,670.786,458.746,306.566,305.906,096.564,287.602,046.012,035.691,884.14
Gross Profit1,563.981,792.601,882.431,814.281,644.831,193.23751.28770.15711.64
Selling, General and Administrative Excl. Other771.47740.84728.35755.64804.75599.65335.71336.16329.67
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income792.511,051.761,154.081,058.63840.08593.58415.57434.00381.97
Interest Expense212.45197.49237.24336.70229.73182.4213.0213.2813.50
Unusual Expense41.32569.61121.7089.5770.84229.3718.090.0012.49
Net Income Before Taxes517.89252.47803.76624.47567.85196.68381.21426.99364.61
Income Taxes85.5323.1364.6311.7559.4141.3347.8851.1341.96
Consolidated Net Income448.66229.34739.13612.34505.30153.19332.96375.86322.66
Net Income From Continuing Operations448.66229.34739.13612.34505.30153.19332.33373.99322.66
Net Income448.66229.34739.13612.34505.30153.19332.33373.99322.66
EPS (Recurring)6.177.959.938.166.734.616.476.886.05
EPS (Basic, Before Extraordinaries)5.852.928.967.466.202.286.296.945.96
EPS (Diluted)5.802.908.907.406.132.256.246.885.89
EBITDA1,199.561,470.871,682.371,686.131,454.81953.91510.17525.92447.89
Non-Operating Income (Expense)-20.87-32.198.61-7.9028.3414.89-3.256.278.64
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense76.1882.5836.2443.98123.42153.3922.9923.4727.64
Price To Earnings Ratio35.2735.2723.3545.1934.09104.5731.0324.8021.67
Price To Sales Ratio1.601.742.132.882.073.853.713.342.73
Gross Margin18.9921.7222.9922.3421.2521.7726.8627.4527.42
Operating Margin9.6212.7514.0913.0410.8510.8314.8615.4714.72
Net Margin5.452.789.037.546.532.7911.8813.3312.43
Shares Outstanding74.9276.5780.7682.5081.7281.5552.7953.6253.97
Market Capitalization15,330.2015,330.2017,313.5323,304.3015,836.5425,208.9010,290.119,238.597,033.68

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue2,024.762,063.492,034.002,112.522,084.412,039.092,015.322,041.10
Cost of Goods Sold Incl. D&A1,627.351,674.961,646.401,722.071,637.981,553.481,545.221,538.39
Gross Profit397.41388.53387.60390.45446.43485.61470.10502.71
Selling, General and Administrative Excl. Other196.85194.32200.60179.70197.05205.01198.38151.45
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income200.56194.21187.00210.75249.38280.61271.72351.26
Interest Expense66.1848.7948.0049.4950.2450.1547.6151.43
Unusual Expense1.7223.4313.262.90472.3049.6744.7554.24
Net Income Before Taxes138.2892.20127.56159.85-271.39182.84181.16248.60
Income Taxes32.4519.6222.8110.6612.79-20.6720.35-11.40
Consolidated Net Income122.1372.58104.75149.19-284.18203.52160.81260.00
Net Income From Continuing Operations122.1372.58104.75149.19-284.18203.52160.81260.00
Net Income122.1372.58104.75149.19-284.18203.52160.81260.00
EPS (Recurring)1.591.151.481.960.603.002.373.62
EPS (Basic, Before Extraordinaries)1.590.941.371.95-3.672.572.003.18
EPS (Diluted)1.580.941.361.93-3.672.561.993.16
EBITDA311.69293.88286.31307.68358.91387.92377.06517.53
Non-Operating Income (Expense)5.61-29.791.821.491.762.051.803.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.2215.3521.3225.2835.4912.059.76410.11
Price To Earnings Ratio35.2780.0114.9624.6317.9915.8218.3523.35
Price To Sales Ratio1.601.621.031.711.661.421.732.08
Gross Margin19.6318.8319.0618.4821.4223.8223.3324.63
Operating Margin9.919.419.199.9811.9613.7613.4817.21
Net Margin6.033.525.157.06-13.639.987.9812.74
Shares Outstanding74.9277.1576.6076.5777.7782.8282.6880.76
Market Capitalization15,330.2013,300.518,449.9913,914.3013,610.1211,746.0914,131.6517,313.53

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments647.30538.79380.06290.48753.93842.03569.94455.76360.45
Short Term Receivables2,749.062,595.952,899.312,801.492,072.951,207.471,013.53837.62706.19
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets105.32140.44132.11137.09114.3253.4841.5236.8034.38
Total Current Assets3,501.683,275.173,411.473,229.072,941.202,102.981,624.981,330.181,101.02
Net Property, Plant & Equipment524.67530.48501.52504.15534.57258.90270.06158.67163.05
Total Investments and Advances82.0557.9546.8032.6324.9720.3010.056.960.00
Long-Term Note Receivable75.7184.190.0021.3818.6417.2317.2320.0218.40
Intangible Assets11,978.8112,611.2012,877.9413,250.3313,748.771,002.72951.06810.32840.69
Deferred Tax Assets106.8775.8373.6676.9348.3912.7116.6813.588.07
Other Assets0.000.0078.4770.7970.5620.7717.4414.5315.39
Total Assets16,269.7816,634.8216,989.8617,185.2817,387.093,435.612,907.512,354.262,146.62
Short Term Debt Incl. Current Port. of LT Debt566.0466.55146.5698.81105.1024.33377.960.000.00
Accounts Payable192.12173.03131.5881.1990.7651.1124.0513.2918.59
Income Tax Payable19.0055.2613.9741.7859.4312.1812.035.7214.97
Other Current Liabilities2,419.022,340.662,533.492,468.822,223.641,036.32717.21591.61532.50
Total Current Liabilities3,196.182,635.492,825.612,690.602,478.941,123.941,131.25610.62566.06
Long Term Debt2,989.743,536.483,791.764,730.685,540.65409.2876.59349.26348.89
Provision for Risks Charges0.000.0014.7413.0316.2611.139.615.404.66
Deferred Tax Liabilities714.43811.23899.10988.591,085.9810.419.488.217.72
Other Liabilities176.06210.26217.91264.42197.7129.7822.2125.6027.33
Total Liabilities7,076.407,193.477,749.128,687.329,319.531,584.531,249.13999.10954.65
Non-Equity Reserves0.000.000.000.000.740.840.810.880.97
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity9,193.389,441.359,240.748,497.968,066.831,850.241,618.061,354.281,191.00
Total Shareholders Equity9,193.389,441.359,240.748,497.968,066.831,850.241,618.061,354.281,191.00
Accumulated Minority Interest0.000.000.000.000.000.0039.510.000.00
Total Equity9,193.389,441.359,240.748,497.968,066.831,850.241,657.571,354.281,191.00
Total Liabilities & Stockholders Equity16,269.7816,634.8216,989.8617,185.2817,387.093,435.612,907.512,354.262,146.62
Book Value Per Share120.07116.91112.02103.9898.9135.0530.1825.0922.02
Tangible Book Value Per Share-36.38-39.25-44.09-58.15-69.6716.0612.4410.086.48
Full-Time Employees40,10041,90041,10041,10038,33015,73014,65013,67013,250
Price to Book Ratio1.681.772.601.933.135.565.715.155.39
Return on Assets1.384.403.582.921.4710.4814.2214.3414.17
Return on Equity2.457.916.906.103.0919.1625.1625.3526.35
Return on Invested Capital1.885.704.703.821.1314.7122.0718.9418.28
Quick Ratio1.101.241.211.201.191.871.442.181.95
Current Ratio1.101.241.211.201.191.871.442.181.95

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income449.44229.34739.13612.34505.30153.19332.96375.86322.66
Depreciation402.53419.11528.29627.50614.73120.8294.6191.9265.92
Other Funds (Non Cash)75.93614.78123.95121.42118.49450.4329.1429.0428.50
Funds from Operations881.781,134.311,288.471,275.851,113.54663.82457.63495.29418.72
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital117.60-98.10-1.82-114.82-550.22135.00108.85-82.74-150.91
Income Taxes Payable-------1.770.73-5.22
Cash from Operating Activities999.381,036.211,286.651,161.03563.32798.81566.48412.54267.82
Capital Expenditures-169.67-174.21-168.06-140.69-142.16-93.75-51.06-50.65-48.40
Net Assets From Acquisitions0.04-2.54-84.16-71.770.00-5,914.48-91.85-131.27-1.65
Sale of Fixed Assets and Businesses-56.630.000.000.000.000.0010.1711.700.00
Purchase or Sale of Investments-26.05-10.78-14.57-14.20-3.71-16.0142.248.1912.75
Purchase of Investments-36.10-19.87-17.26-16.81-6.09-16.51-5.66-13.49-87.12
Sale Or Maturity of Investments10.049.092.692.622.390.5047.9021.6999.87
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-252.31-187.53-266.79-226.65-145.87-6,024.24-90.50-162.03-37.30
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-370.09-740.75-464.2250.96-64.17117.74-161.95-125.41-112.20
Repurchase of Common Pref Stock-385.40-750.45-500.390.00-100.000.00-175.14-147.04-129.03
Sale of Common Pref Stock15.319.7136.1750.9635.83117.7413.1921.6316.83
Proceedsfrom Stock Options-0.02-0.02-0.02-0.02-0.02-0.85-0.01-0.0116.83
Issuance or Reduction of Debt, Net-32.43-30.51-372.96-895.00-800.005,027.320.000.000.00
Change in Long Term Debt-32.43-30.51-372.96-895.000.000.000.000.000.00
Issuance of Long Term Debt2,624.5249.252,304.80370.000.000.000.000.000.00
Reduction of Long Term Debt-2,656.95-79.76-2,677.76-1,265.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00-0.910.000.00
Other Financing Activities Uses0.000.000.000.000.000.00-0.910.000.00
Cash from Financing Activities-402.52-771.26-837.18-844.04-864.175,145.06-162.86-125.41-112.20
Exchange Rate Effect0.7131.10-22.00-1.00-16.72-7.736.87-0.65-5.33
Net Change in Cash345.25108.51160.6889.33-463.45-88.09320.00124.46112.99
Free Cash Flow829.71861.991,118.591,020.34421.15705.06515.43361.90219.42
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow15.8616.6915.5722.9538.0429.9020.1625.8632.26
Deferred Taxes & Investment Tax Credit--128.92-102.89-85.40-124.99-60.620.93-1.541.65

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments808.98928.39765.16647.30468.89390.40
Short Term Receivables2,715.872,705.452,698.022,749.062,736.082,704.21
Inventories0.000.000.000.000.000.00
Other Current Assets116.52114.81144.15105.32138.79143.26
Total Current Assets3,641.383,748.653,607.343,501.683,343.763,237.86
Net Property, Plant & Equipment478.33500.29508.36524.67512.28518.33
Total Investments and Advances121.25107.2396.9782.0571.2867.74
Intangible Assets11,822.1811,867.7711,922.4811,978.8112,025.9612,535.51
Deferred Tax Assets105.54107.41109.44106.87103.2788.73
Other Assets0.000.000.000.0011.3911.39
Total Assets16,242.3316,400.3216,319.0216,269.7816,157.8716,544.60
Short Term Debt Incl. Current Port. of LT Debt32.901,312.26564.96566.04529.7629.76
Accounts Payable86.00118.2499.85192.12113.2994.50
Income Tax Payable18.5516.9427.6119.0050.8021.28
Other Current Liabilities2,631.202,487.232,477.122,419.022,538.112,407.08
Total Current Liabilities2,768.663,934.673,169.543,196.183,231.962,552.63
Long Term Debt3,476.252,213.572,978.022,989.743,003.663,517.20
Provision for Risks Charges1.901.601.900.000.000.00
Deferred Tax Liabilities680.94690.32694.32714.43722.11775.19
Other Liabilities187.26182.00174.95176.06206.28198.93
Total Liabilities7,115.017,022.167,018.737,076.407,164.007,043.96
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity9,127.329,378.169,300.309,193.388,993.879,500.65
Total Shareholders Equity9,127.329,378.169,300.309,193.388,993.879,500.65
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity9,127.329,378.169,300.309,193.388,993.879,500.65
Total Liabilities & Stockholders Equity16,242.3316,400.3216,319.0216,269.7816,157.8716,544.60
Book Value Per Share121.83121.55121.41120.07115.64114.72
Tangible Book Value Per Share-35.97-32.27-34.23-36.38-38.99-36.65
Full-Time Employees---40,100--
Price to Book Ratio1.681.430.911.491.421.22
Return on Assets2.770.261.051.382.044.90
Return on Equity4.950.451.852.453.628.61
Return on Invested Capital0.970.630.851.22-2.371.56
Quick Ratio1.320.951.141.101.031.27
Current Ratio1.320.951.141.101.031.27

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income120.0072.01104.75152.69-294.26217.28
Depreciation108.9799.0399.3195.22116.34115.35
Other Funds (Non Cash)0.6245.4316.2413.64530.9449.29
Funds from Operations222.96213.27197.44248.10281.34359.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital102.2264.26-30.44-18.44127.56-197.24
Cash from Operating Activities325.17277.53167.01229.67408.90161.86
Capital Expenditures-37.22-42.18-30.77-59.49-56.68-34.59
Net Assets From Acquisitions0.000.000.000.04-0.02-0.10
Sale of Fixed Assets and Businesses-1.29-55.330.000.000.000.00
Purchase or Sale of Investments-10.75-10.34-8.673.71-2.61-6.38
Purchase of Investments-8.91-14.80-8.93-3.46-4.24-6.85
Sale Or Maturity of Investments-1.844.460.267.161.630.48
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-49.27-107.86-39.44-55.75-59.31-41.06
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-386.221.611.0813.44-264.92-267.08
Repurchase of Common Pref Stock-396.480.000.0011.07-265.83-269.05
Sale of Common Pref Stock10.251.611.082.370.911.98
Proceedsfrom Stock Options-0.01-0.00-0.00-0.00-0.01-0.00
Issuance or Reduction of Debt, Net-9.47-7.39-7.44-8.12-7.91-8.00
Change in Long Term Debt-9.47-7.39-7.44-8.12-7.91-8.00
Issuance of Long Term Debt2,626.030.000.00-1.510.411.89
Reduction of Long Term Debt-2,635.51-7.39-7.44-6.61-8.32-9.89
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-395.70-5.78-6.365.32-272.82-275.08
Exchange Rate Effect-0.16-1.58-3.345.794.1212.37
Net Change in Cash-119.95162.31117.87185.0380.88-141.91
Free Cash Flow287.95235.34136.24170.17352.22127.27
Price to Free Cash Flow15.8615.0310.8815.8513.9411.69

Revenue breakdown

Services-Commercial Physical & Biological Research2024: 8.19B 2025: 8.25B
Ireland2024: 2.70B 2025: 3.18B
Rest Of Europe2024: 1.56B 2025: 1.59B
Rest of World2024: 942.64M 2025: 951.90M
United States2024: 2.98B 2025: 2.52B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.20%2.4M74.1M916.68K
2026-10-153.89%3.0M76.4M840.73K
2026-09-303.67%2.8M76.4M811.31K
2026-09-153.44%2.6M76.4M825.44K
2026-08-313.12%2.4M76.4M855.47K
2026-08-142.91%2.2M76.3M968.06K
2026-07-312.91%2.2M76.4M1.02M
2026-07-153.42%2.6M75.9M1.17M
2026-06-303.94%3.0M75.9M1.20M
2026-06-154.27%3.2M75.9M1.15M
2026-05-293.96%3.0M75.9M1.16M
2026-05-154.35%3.3M75.7M1.30M
2026-04-303.53%2.7M75.9M1.98M
2026-04-154.08%3.1M75.9M1.80M
2026-03-313.82%2.9M75.8M1.86M
2026-03-132.68%2.0M75.8M1.81M
2026-02-272.55%1.9M75.8M1.76M
2026-02-132.64%2.0M75.8M1.60M
2026-01-303.73%2.8M75.8M889.50K
2026-01-153.68%2.7M74.5M974.88K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12078.8082.800.002.2990.000.000.942-0.4980.036
call12574.0077.600.002.1220.000.000.938-0.4910.038
call13068.8072.800.001.9990.000.000.934-0.4830.040
call13563.8067.600.001.8350.000.000.928-0.4820.043
call14059.1063.0063.001.7424.000.000.923-0.4720.045
call14554.3057.900.001.6360.000.000.916-0.4690.048
call15049.6053.000.001.4950.000.000.908-0.4650.052
call15544.0048.0016.801.3651.000.000.899-0.4580.055
call16039.4043.1017.301.2792.000.000.888-0.4570.060
call16534.8038.0018.501.1440.000.000.874-0.4520.065
call17029.3033.2034.501.0387.000.000.860-0.4380.070
call17525.7028.4028.120.93610.000.000.843-0.4160.075
call18020.5023.6027.000.8313.000.000.814-0.4190.084
call18515.9019.109.800.7471220.000.780-0.4020.093
call19012.2015.1013.950.7121061.000.732-0.3770.103
call1959.2011.5024.260.6683080.000.644-0.4010.117
call2006.408.107.600.6142041.000.538-0.4200.124
call2102.703.802.950.58980312.000.331-0.3850.113
call2200.702.302.900.6742330.000.204-0.3400.089
call2300.002.151.100.8052250.000.168-0.3590.079
call2400.002.301.650.8621,1170.000.127-0.3210.067
call2500.002.150.221.0481.000.000.115-0.3620.062
put1200.002.150.002.3530.000.00-0.053-0.4490.035
put1250.002.150.002.2020.000.00-0.056-0.4420.036
put1300.002.152.382.05790.000.00-0.060-0.4340.038
put1350.002.201.781.93891.000.00-0.070-0.4560.042
put1400.002.202.701.8263.000.00-0.073-0.4480.045
put1450.002.250.401.68031.000.00-0.081-0.4450.048
put1500.002.300.351.56025.000.00-0.085-0.4270.050
put1550.002.351.161.4319.000.00-0.092-0.4150.053
put1600.002.450.671.3059.000.00-0.100-0.4020.056
put1650.002.554.691.19667.000.00-0.116-0.4100.062
put1700.002.800.701.0651.000.00-0.124-0.3820.065
put1750.002.601.051.00992.000.00-0.160-0.4300.077
put1800.002.900.000.8850.000.00-0.176-0.3990.082
put1850.053.101.850.73749.000.00-0.223-0.3870.094
put1901.053.101.900.5903.000.00-0.276-0.3650.104
put1952.604.203.350.54855.003.00-0.356-0.3790.117
put2004.706.505.250.5523081.00-0.465-0.3970.124
put21010.6013.106.800.60552.000.00-0.668-0.3620.114
put22018.6021.200.000.6380.000.00-0.795-0.3140.089
put23027.8031.4022.200.8484.000.00-0.836-0.3430.078
put24037.4041.2069.800.9874.000.00-0.857-0.3750.071
put25047.4051.000.001.1060.000.00-0.871-0.4010.066

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-10SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-31SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-31SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-31SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-30SEC
2026-10-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-27SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-08SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-16SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-184Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-17144Filing for proposed sale of securities under Rule 144.SEC
2026-09-17144Filing for proposed sale of securities under Rule 144.SEC
2026-09-16144Filing for proposed sale of securities under Rule 144.SEC
2026-09-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-09SEC
2026-08-206-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-20SEC
2026-08-186-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-14SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11002.14M4
2026-100049.60K1
2026-09002.32M3
2026-08001.72M9
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Artisan Partners Limited Partnership11.28%
FMR LLC8.55%
WELLINGTON MANAGEMENT GROUP LLP6.95%
Invesco Ltd.6.88%
HARRIS ASSOCIATES L P5.84%
Brave Warrior Advisors, LLC4.12%
GREENHAVEN ASSOCIATES INC3.98%
PRINCIPAL FINANCIAL GROUP INC3.81%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2.75%
Ruane, Cunniff & Goldfarb L.P.2.67%

Funds

Fund% owned
BlackRock Strategic Income Opportunities Portfolio47.80%
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND32.84%
DFA INTERNATIONAL SMALL CAP VALUE PORTFOLIO24.10%
VANGUARD DEVELOPED MARKETS INDEX FUND21.69%
iShares Core MSCI EAFE ETF16.43%
VANGUARD TOTAL INTERNATIONAL BOND INDEX FUND13.06%
VANGUARD TOTAL INTERNATIONAL BOND II INDEX FUND13.06%
Dimensional International Value ETF10.43%
Artisan International Value Fund8.81%
Fidelity International Index Fund8.68%

OakChart. ICLR. Cached 15 minutes.